Literature DB >> 8043032

Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione.

C Schewe1, T Schewe, A Wendel.   

Abstract

Both human recombinant 5-lipoxygenase (EC 1.13.11.34) and 15-lipoxygenase (EC 1.13.11.33, mammalian enzyme) purified from rabbit reticulocytes were inhibited in the absence of glutathione (GSH) by submicromolar concentrations of the seleno-organic compound ebselen. These concentrations were comparable to those of the enzymes. Soybean lipoxygenase-1 (EC 1.13.11.33, plant enzyme) was not inhibited, whereas prostaglandin endoperoxide synthase-1 (EC 1.14.99.1) was inhibited only at much higher concentrations of ebselen (IC50 = 37.7 +/- 4.3 microM). The action of ebselen on reticulocyte 15-lipoxygenase (IC50 = 0.17 +/- 0.01 microM) was studied in detail. Inhibition occurred instantaneously and appeared to be reversible and was largely abolished by a 20-fold molar excess of GSH over ebselen. In the presence of 1 mM GSH 50% inhibition was observed only at ebselen concentrations as high as 234 +/- 27 microM. 13S-hydroperoxy-9Z, 11E-octadecadienoic acid, the lipoxygenase product formed from linoleic acid, augmented the inhibitory effect at low concentrations and caused a partial reversal at high concentrations. A variety of derivatives or structural analogues of ebselen were also tested and proved to be either inactive or weaker inhibitors of 15-lipoxygenase. We have concluded that the potent inhibition of 15-lipoxygenase by ebselen is due neither to GSH peroxidase-like activity nor to lowering of the hydroperoxide tone. The pharmacological implications of these unique characteristics of the action of ebselen on lipoxygenases are then discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043032     DOI: 10.1016/0006-2952(94)90224-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.

Authors:  Susan M E Smith; Jaeki Min; Thota Ganesh; Becky Diebold; Tsukasa Kawahara; Yerun Zhu; James McCoy; Aiming Sun; James P Snyder; Haian Fu; Yuhong Du; Iestyn Lewis; J David Lambeth
Journal:  Chem Biol       Date:  2012-06-22

2.  Synthesis of Novel Selenides Bearing Benzenesulfonamide Moieties as Carbonic Anhydrase I, II, IV, VII, and IX Inhibitors.

Authors:  Andrea Angeli; Damiano Tanini; Antonella Capperucci; Claudiu T Supuran
Journal:  ACS Med Chem Lett       Date:  2017-11-07       Impact factor: 4.345

3.  Helicobacter pylori reduces intracellular glutathione in gastric epithelial cells.

Authors:  W Beil; B Obst; K F Sewing; S Wagner
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

4.  Ebselen induced C6 glioma cell death in oxygen and glucose deprivation.

Authors:  Honglian Shi; Shimin Liu; Minoru Miyake; Ke Jian Liu
Journal:  Chem Res Toxicol       Date:  2006-05       Impact factor: 3.739

5.  Ebselen protects Ca2+ influx blockage but does not protect glutamate uptake inhibition caused by Hg2+.

Authors:  M B Moretto; J Franco; T Posser; C W Nogueira; G Zeni; J B T Rocha
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

6.  Ebselen is a potent non-competitive inhibitor of extracellular nucleoside diphosphokinase.

Authors:  Lucia Semianrio-Vidal; Catharina van Hesuden; Govindasamy Mugesh; Eduardo Rodolfo Lazarowski
Journal:  Purinergic Signal       Date:  2010-11-03       Impact factor: 3.765

7.  Reactive oxygen species (ROS) from NADPH and xanthine oxidase modulate the cutaneous local heating response in healthy humans.

Authors:  Marvin S Medow; Natasha Bamji; Debbie Clarke; Anthony J Ocon; Julian M Stewart
Journal:  J Appl Physiol (1985)       Date:  2011-03-24

Review 8.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

9.  Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs.

Authors:  Yuren Wang; Jason Wallach; Stephanie Duane; Yuan Wang; Jianghong Wu; Jeffrey Wang; Adeboye Adejare; Haiching Ma
Journal:  Drug Des Devel Ther       Date:  2017-05-02       Impact factor: 4.162

10.  NADPH oxidase 2 inhibitors CPP11G and CPP11H attenuate endothelial cell inflammation & vessel dysfunction and restore mouse hind-limb flow.

Authors:  Y Li; E Cifuentes-Pagano; E R DeVallance; D S de Jesus; S Sahoo; D N Meijles; D Koes; C J Camacho; M Ross; C St Croix; P J Pagano
Journal:  Redox Biol       Date:  2019-02-15       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.